4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-24-003505
Director sold 29,350 shares at an average $86.67 ($2,543,737)
- Director acquired 29,350 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
MUSSALLEM MICHAEL A · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-04 | Exercise or conversion : show line 1 in the form 10b5-1 | +29,350 | $36.75 | $1,078,613 | 33,835.82 | D |
| 2024-03-04 | Sale : show line 2 in the form 10b5-1 | −13,310 | $86.21 | $1,147,455 | 20,525.82 | D |
| 2024-03-04 | Sale : show line 3 in the form 10b5-1 | −16,040 | $87.05 | $1,396,282 | 4,485.82 | D |
| Open-market sales · 29,350 sh · avg $86.67 · $2,543,737 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2024-03-04 | Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −29,350 | $36.75 | 2024-05-10 | 29,350 | 58,700 | D |
Loading xslF345X05/doc4.xml…